Tag Archives: COPD

Distinct COPD Subgroup Identified by Airway Epithelial IL-17 Response

November 22, 2018 Share this content: The IL-17 response is associated with increases in airway neutrophils and macrophages and is related to worse clinical outcomes in current and former smokers. Gene expression of airway epithelial interleukin (IL)-17 response distinguishes a biologically, radiographically, and clinically distinct chronic obstructive pulmonary disease (COPD) subgroup of patients who may… Read More »

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)

Home News New Drugs FDA Approves Yupelri FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD) Print this page November 09, 2018 — Today, the U.S. Food and Drug Administration (FDA) approved Yupelri (revefenacin) Inhalation Solution for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Revefenacin is a long-acting muscarinic antagonist… Read More »

Half of COPD Inhaler Use Does Not Align With GOLD Recommendations

November 01, 2018 Share this content: Participants were stratified into aligned with inhaler regimen to first-/second-line GOLD recommendations or nonaligned with recommendations. Approximately half of patients with chronic obstructive pulmonary disease (COPD) who use inhaler medications report use that is not in alignment with current treatment recommendations, according to an analysis of participants in the… Read More »